Consort Medical plc (CSRT) Receives Average Rating of “Buy” from Analysts
Shares of Consort Medical plc (LON:CSRT) have earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is GBX 1,153.17 ($14.69).
A number of research firms have issued reports on CSRT. Numis Securities Ltd reiterated a “hold” rating and set a GBX 1,084 ($13.81) target price on shares of Consort Medical plc in a report on Thursday. Panmure Gordon reiterated a “buy” rating and set a GBX 1,145 ($14.59) target price on shares of Consort Medical plc in a report on Thursday. Stifel Nicolaus reiterated a “hold” rating and set a GBX 1,100 ($14.01) target price on shares of Consort Medical plc in a report on Thursday. Investec reiterated a “buy” rating and set a GBX 1,165 ($14.84) target price on shares of Consort Medical plc in a report on Thursday. Finally, N+1 Singer reiterated a “buy” rating and set a GBX 1,125 ($14.33) target price on shares of Consort Medical plc in a report on Thursday.
Consort Medical plc (LON CSRT) traded down 2.71% during mid-day trading on Monday, hitting GBX 1076.00. 10,887 shares of the stock traded hands. The stock’s market cap is GBX 525.66 million. The stock has a 50-day moving average price of GBX 1,044.14 and a 200-day moving average price of GBX 1,028.38. Consort Medical plc has a 12 month low of GBX 940.00 and a 12 month high of GBX 1,180.00.
The company also recently disclosed a dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, September 21st will be issued a GBX 13.21 ($0.17) dividend. This represents a dividend yield of 1.3%. This is a positive change from Consort Medical plc’s previous dividend of $7.09. The ex-dividend date is Thursday, September 21st.
ILLEGAL ACTIVITY NOTICE: “Consort Medical plc (CSRT) Receives Average Rating of “Buy” from Analysts” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/06/19/consort-medical-plc-csrt-receives-average-rating-of-buy-from-analysts.html.
About Consort Medical plc
Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company’s principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica.
Receive News & Ratings for Consort Medical plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Consort Medical plc and related companies with MarketBeat.com's FREE daily email newsletter.